These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8361563)

  • 1. [Endometrial carcinoma during estrogen replacement therapy in spite of addition of progestagens].
    Meuwissen JH; Klinkhamer PJ; Brölmann HA; Wiegerinck MA
    Ned Tijdschr Geneeskd; 1993 Jul; 137(29):1473. PubMed ID: 8361563
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endometrial carcinoma during estrogen replacement therapy in spite of addition of progestagens].
    Ubachs JM; Heineman MJ
    Ned Tijdschr Geneeskd; 1993 May; 137(21):1062-3. PubMed ID: 8506004
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas.
    Jaakkola S; Lyytinen HK; Pukkala E; Ylikorkala O
    Gynecol Oncol; 2011 Aug; 122(2):260-3. PubMed ID: 21531011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of ovarian and uterine cancers with postmenopausal hormonal treatments.
    Neves-E-Castro M
    Clin Obstet Gynecol; 2008 Sep; 51(3):607-17. PubMed ID: 18677154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and gynecological cancer.
    Gadducci A; Fanucchi A; Cosio S; Genazzani AR
    Anticancer Res; 1997; 17(5B):3793-8. PubMed ID: 9427782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estrogens and progestins in hormone replacement therapy in menopause].
    La Vecchia C
    Recenti Prog Med; 2001 Mar; 92(3):209-12. PubMed ID: 11320854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oncologic aspects of estrogen-replacement therapy].
    Berstein LM
    Vopr Onkol; 1998; 44(4):378-82. PubMed ID: 9807197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the problems of the progestogen.
    Sturdee DW; MacLennan AH
    Climacteric; 2006 Aug; 9(4):241-3. PubMed ID: 16857653
    [No Abstract]   [Full Text] [Related]  

  • 9. Is combined estrogen/progestogen hormone therapy worth the risk?
    Sturdee DW; MacLennan AH
    Climacteric; 2003 Sep; 6(3):177-9. PubMed ID: 14567764
    [No Abstract]   [Full Text] [Related]  

  • 10. Postmenopausal hormone-replacement therapy.
    Hilmy N
    N Engl J Med; 2002 Jan; 346(1):63-5. PubMed ID: 11799954
    [No Abstract]   [Full Text] [Related]  

  • 11. A practical guide to prescribing estrogen replacement therapy.
    Corson SL
    Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-progestin increases breast cancer risk.
    Stephens MB
    J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone replacement therapy in women with breast cancer.
    Braendle W
    Anticancer Res; 1998; 18(3C):2253-5. PubMed ID: 9703796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soy phytoestrogens: an adjunct to hormone replacement therapy?
    Birge SJ
    Menopause; 2000; 7(4):209-12. PubMed ID: 10914612
    [No Abstract]   [Full Text] [Related]  

  • 15. Bleeding with menopausal hormone therapy: physiological or pathological?
    Hickey M
    Menopause Int; 2007 Dec; 13(4):188-90. PubMed ID: 18088532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progestins and recurrence in breast cancer survivors.
    Chlebowski RT; Anderson GL
    J Natl Cancer Inst; 2005 Apr; 97(7):471-2. PubMed ID: 15812065
    [No Abstract]   [Full Text] [Related]  

  • 17. [Expert meeting on the effect of sex hormones on the normal breast: moderately increased risk of cancer, but the connection is still not clear].
    von Schoultz B; Bergkvist L; Magnusson C; von Schoultz E
    Lakartidningen; 2000 May; 97(18):2225-6. PubMed ID: 10850053
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormone replacement therapy in menopause and lung cancer: an update.
    La Vecchia C
    Eur J Cancer Prev; 2006 Jun; 15(3):189-90. PubMed ID: 16679859
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone replacement therapy and ovarian cancer risk--any news?
    Riman T
    Acta Obstet Gynecol Scand; 2007; 86(9):1032-4. PubMed ID: 17712640
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormone therapy and thromboembolic disease.
    Battaglioli T; Martinelli I
    Curr Opin Hematol; 2007 Sep; 14(5):488-93. PubMed ID: 17934355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.